NALTREXONE HYDROCHLORIDE

NALTREXONE HYDROCHLORIDE was reported 8503 times

NALTREXONE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTI-SACCHAROMYCES CEREVISIAE ANTIBODY TEST POSITIVE 1 0.1429
1 BODY TINEA 50 0.0893
2 GASTRITIS FUNGAL 5 0.0485
3 BARTONELLOSIS 3 0.0455
4 PAEDIATRIC ACUTE-ONSET NEUROPSYCHIATRIC SYNDROME 2 0.0426
5 BIOPSY COLON 1 0.0417
6 CERVICECTOMY 1 0.0357
7 BINGE DRINKING 4 0.0354
8 INHIBITORY DRUG INTERACTION 49 0.0309
9 CESTODE INFECTION 2 0.0274
10 BIOPSY ENDOMETRIUM 1 0.0256
11 AUTOIMMUNE EYE DISORDER 1 0.0238
12 INFECTION SUSCEPTIBILITY INCREASED 50 0.0228
13 ACETONAEMIA 5 0.0198
14 ANORECTAL STENOSIS 1 0.0189
15 MYOGLOBINURIA 10 0.0188
16 CONFUSIONAL AROUSAL 3 0.0186
17 CATHETER SITE PAPULE 1 0.0185
18 ALLERGY TO IMMUNOGLOBULIN THERAPY 2 0.0183
19 ANORECTAL MALFORMATION 1 0.0179
20 BORRELIA TEST POSITIVE 1 0.0167
21 ALCOHOL DETOXIFICATION 1 0.0112
22 BRCA2 GENE MUTATION 1 0.0105
23 ABORTION SPONTANEOUS INCOMPLETE 1 0.0103
24 BILE DUCT STENOSIS 12 0.0100
25 ARTIFICIAL MENOPAUSE 1 0.0094
26 GLUCOSE TOLERANCE IMPAIRED 51 0.0086
27 BILIARY DILATATION 12 0.0082
28 VASCULAR ACCESS SITE COMPLICATION 2 0.0079
29 CEREBRAL CALCIFICATION 2 0.0075
30 ATYPICAL MYCOBACTERIAL PNEUMONIA 1 0.0072
31 ADDISON'S DISEASE 1 0.0069
32 ANTICONVULSANT DRUG LEVEL ABOVE THERAPEUTIC 4 0.0062
33 CONTRAINDICATED PRODUCT PRESCRIBED 10 0.0059
34 CHOLANGITIS SCLEROSING 12 0.0058
35 CENTRAL NERVOUS SYSTEM STIMULATION 1 0.0056
36 PURPURA 50 0.0056
37 BRAIN MALFORMATION 2 0.0056
38 CATHETER SITE INDURATION 1 0.0052
39 CATHETER SITE VESICLES 1 0.0051
40 JUDGEMENT IMPAIRED 7 0.0048
41 CD4 LYMPHOCYTES ABNORMAL 1 0.0048
42 ORGANIC ERECTILE DYSFUNCTION 2 0.0047
43 AMYOTROPHIC LATERAL SCLEROSIS 10 0.0046
44 SLOW SPEECH 11 0.0045
45 HYPERLIPIDAEMIA 53 0.0044
46 BREAST LUMP REMOVAL 1 0.0044
47 IMPAIRED QUALITY OF LIFE 62 0.0043
48 MAGNESIUM DEFICIENCY 2 0.0043
49 MASTOCYTOSIS 2 0.0042
50 MYOFASCIAL PAIN SYNDROME 3 0.0042
51 BRONCHOSCOPY 1 0.0042
52 BUTTOCK PAIN 1 0.0042
53 SLEEP ATTACKS 2 0.0042
54 IMMUNODEFICIENCY COMMON VARIABLE 2 0.0041
55 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 5 0.0037
56 MYCOTIC ALLERGY 3 0.0035
57 CARDIO-RESPIRATORY DISTRESS 1 0.0035
58 ALLERGIC SINUSITIS 3 0.0035
59 DRUG TITRATION ERROR 9 0.0035
60 ALCOHOL WITHDRAWAL SYNDROME 3 0.0034
61 INFUSION SITE DISCHARGE 6 0.0034
62 DEVICE MAINTENANCE ISSUE 2 0.0034
63 ANTEROGRADE AMNESIA 2 0.0033
64 POOR QUALITY SLEEP 71 0.0033
65 ALLERGY TO ARTHROPOD BITE 1 0.0031
66 CATHETER SITE BRUISE 1 0.0030
67 CATHETER SITE IRRITATION 1 0.0030
68 INFUSION SITE URTICARIA 2 0.0030
69 LICHEN SCLEROSUS 2 0.0029
70 CHRONIC FATIGUE SYNDROME 4 0.0029
71 MAST CELL ACTIVATION SYNDROME 4 0.0028
72 IMPAIRED WORK ABILITY 60 0.0028
73 PARASOMNIA 2 0.0028
74 SOMATIC SYMPTOM DISORDER 3 0.0028
75 INFUSION SITE MASS 3 0.0028
76 ANKLE ARTHROPLASTY 1 0.0028
77 ORAL HERPES 53 0.0027
78 ANISOCORIA 1 0.0026
79 VEIN COLLAPSE 2 0.0026
80 CARDIOVASCULAR SYMPTOM 1 0.0026
81 ADRENAL GLAND CANCER 1 0.0026
82 CATHETER SITE EXTRAVASATION 1 0.0025
83 PATHOLOGICAL GAMBLING 4 0.0024
84 LYME DISEASE 8 0.0024
85 BLOOD CHOLESTEROL ABNORMAL 11 0.0024
86 PERIORBITAL PAIN 2 0.0024
87 LIP PRURITUS 2 0.0023
88 CATHETER SITE PRURITUS 2 0.0023
89 FOOD CRAVING 12 0.0023
90 BIPOLAR I DISORDER 5 0.0023
91 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 2 0.0022
92 DRUG DETOXIFICATION 2 0.0022
93 RESPIRATORY TRACT INFECTION VIRAL 5 0.0021
94 CENTRAL VENOUS CATHETER REMOVAL 1 0.0021
95 CATAPLEXY 3 0.0021
96 DEVICE RELATED THROMBOSIS 2 0.0020
97 EYELID PAIN 4 0.0020
98 BLOOD GASES ABNORMAL 1 0.0019
99 INFUSION SITE BRUISING 4 0.0019
100 PILOERECTION 2 0.0018
101 BOWEL MOVEMENT IRREGULARITY 14 0.0018
102 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 4 0.0018
103 APNOEIC ATTACK 1 0.0018
104 DISTRACTIBILITY 2 0.0017
105 PROGRESSIVE MULTIPLE SCLEROSIS 2 0.0017
106 HYPORESPONSIVE TO STIMULI 2 0.0017
107 BLOOD OESTROGEN INCREASED 1 0.0017
108 URINE FLOW DECREASED 4 0.0017
109 SKIN DISORDER 55 0.0016
110 DUODENITIS 5 0.0016
111 POST-ACUTE COVID-19 SYNDROME 2 0.0016
112 PALATAL OEDEMA 2 0.0016
113 SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS 3 0.0016
114 BONE DENSITY DECREASED 50 0.0016
115 ANAL INFLAMMATION 1 0.0016
116 INFUSION SITE IRRITATION 2 0.0016
117 ATROPHY 3 0.0015
118 TONIC CLONIC MOVEMENTS 2 0.0015
119 ANXIETY DISORDER 5 0.0015
120 SUBSTANCE ABUSE 12 0.0015
121 INFUSION SITE RASH 2 0.0015
122 PREMENSTRUAL SYNDROME 2 0.0015
123 PRE-EXISTING CONDITION IMPROVED 9 0.0014
124 ANTIPSYCHOTIC DRUG LEVEL INCREASED 4 0.0014
125 ALCOHOL INTOLERANCE 1 0.0014
126 BORDERLINE PERSONALITY DISORDER 1 0.0014
127 CONNECTIVE TISSUE DISORDER 2 0.0014
128 HEPATIC ENZYME ABNORMAL 7 0.0014
129 HYPERAMMONAEMIA 7 0.0014
130 PORPHYRIA ACUTE 2 0.0014
131 ANTIBODY TEST ABNORMAL 1 0.0014
132 ALANINE AMINOTRANSFERASE DECREASED 1 0.0014
133 SLEEP PARALYSIS 2 0.0014
134 SEROTONIN SYNDROME 26 0.0014
135 INFUSION SITE INDURATION 2 0.0013
136 CATHETER SITE RELATED REACTION 1 0.0013
137 IMPULSIVE BEHAVIOUR 5 0.0013
138 ALLERGIC COUGH 1 0.0013
139 INFUSION SITE INFECTION 3 0.0013
140 BACTERIAL VAGINOSIS 2 0.0013
141 BLOOD ALCOHOL INCREASED 1 0.0013
142 INFUSION SITE SWELLING 8 0.0013
143 SCLERITIS 2 0.0012
144 ABDOMINAL SYMPTOM 1 0.0012
145 INFUSION SITE HAEMORRHAGE 4 0.0012
146 SUSPECTED COVID-19 4 0.0012
147 CARDIAC STRESS TEST ABNORMAL 1 0.0012
148 TYMPANIC MEMBRANE PERFORATION 2 0.0012
149 CELLULITIS 59 0.0012
150 ALCOHOLISM 5 0.0012
151 MYOPATHY 10 0.0012
152 PUPIL FIXED 2 0.0012
153 PRODUCT ADMINISTRATION INTERRUPTED 9 0.0011
154 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 3 0.0011
155 HANGOVER 4 0.0011
156 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 10 0.0011
157 NYSTAGMUS 6 0.0011
158 DRUG WITHDRAWAL CONVULSIONS 2 0.0011
159 ALCOHOL ABUSE 3 0.0011
160 INSURANCE ISSUE 17 0.0011
161 VASCULAR DEVICE INFECTION 5 0.0011
162 DEVICE ALARM ISSUE 2 0.0011
163 INFUSION SITE PAIN 14 0.0011
164 EOSINOPHILIC OESOPHAGITIS 3 0.0011
165 DENTAL CARE 2 0.0011
166 NEURODERMATITIS 4 0.0011
167 HERPES ZOSTER 60 0.0010
168 VITAMIN B12 DECREASED 3 0.0010
169 VOMITING PROJECTILE 3 0.0010
170 ANAL INCONTINENCE 9 0.0010
171 OBSESSIVE-COMPULSIVE DISORDER 8 0.0010
172 CATARACT 58 0.0010
173 BLADDER DYSFUNCTION 1 0.0010
174 BLOOD TRIGLYCERIDES INCREASED 17 0.0010
175 INSULIN RESISTANCE 2 0.0010
176 BODY TEMPERATURE FLUCTUATION 2 0.0010
177 INFUSION SITE PRURITUS 3 0.0009
178 CARPAL TUNNEL DECOMPRESSION 1 0.0009
179 INCORRECT DRUG ADMINISTRATION RATE 4 0.0009
180 ALLERGY TO ANIMAL 1 0.0009
181 CATHETER SITE ERYTHEMA 2 0.0009
182 MULTIPLE DRUG OVERDOSE INTENTIONAL 3 0.0009
183 EXOPHTHALMOS 2 0.0009
184 HYPERPROLACTINAEMIA 6 0.0009
185 ACCIDENT AT WORK 2 0.0009
186 CYTOLYTIC HEPATITIS 3 0.0009
187 FAECES PALE 2 0.0009
188 POST-TRAUMATIC STRESS DISORDER 6 0.0009
189 IMPLANT SITE PAIN 4 0.0009
190 JOINT RANGE OF MOTION DECREASED 12 0.0009
191 CATHETER SITE DISCHARGE 1 0.0009
192 DERMATITIS CONTACT 10 0.0009
193 HEPATIC FIBROSIS 3 0.0009
194 CENTRAL NERVOUS SYSTEM INFECTION 1 0.0009
195 ACUTE PRERENAL FAILURE 1 0.0009
196 THINKING ABNORMAL 16 0.0009
197 GASTRITIS EROSIVE 4 0.0009
198 SKIN ABRASION 4 0.0008
199 PANCREATITIS CHRONIC 2 0.0008
200 MUSCULOSKELETAL CHEST PAIN 13 0.0008
201 INFUSION SITE ERYTHEMA 7 0.0008
202 HEPATITIS CHOLESTATIC 5 0.0008
203 INFLAMMATORY BOWEL DISEASE 8 0.0008
204 FEELING DRUNK 6 0.0008
205 DEVICE INFUSION ISSUE 2 0.0008
206 ALLERGY TO CHEMICALS 1 0.0008
207 PERSECUTORY DELUSION 2 0.0008
208 CHRONIC SINUSITIS 3 0.0008
209 AORTIC VALVE REPLACEMENT 1 0.0008
210 CAROTID ARTERY DISEASE 1 0.0008
211 GASTRIC INFECTION 3 0.0008
212 VIRAL INFECTION 26 0.0008
213 FOOD ALLERGY 6 0.0008
214 MENOPAUSE 2 0.0008
215 CATHETER SITE PAIN 2 0.0008
216 ORAL INFECTION 3 0.0008
217 MULTIPLE ALLERGIES 6 0.0008
218 ABNORMAL SLEEP-RELATED EVENT 1 0.0008
219 OBSTRUCTION 3 0.0008
220 ANIMAL BITE 2 0.0007
221 ENURESIS 3 0.0007
222 BODY MASS INDEX INCREASED 1 0.0007
223 EAR CONGESTION 2 0.0007
224 BILIARY TRACT DISORDER 1 0.0007
225 DIABETIC COMA 2 0.0007
226 BLOOD GLUCOSE ABNORMAL 13 0.0007
227 HEAD INJURY 22 0.0007
228 SOCIAL AVOIDANT BEHAVIOUR 4 0.0007
229 UPPER RESPIRATORY TRACT CONGESTION 2 0.0007
230 URINE OUTPUT DECREASED 6 0.0007
231 CARDIAC FIBRILLATION 1 0.0007
232 ARTHROPOD BITE 5 0.0007
233 URINE ANALYSIS ABNORMAL 2 0.0007
234 CONTUSION 64 0.0007
235 SCRATCH 7 0.0007
236 ADHESION 1 0.0007
237 IRITIS 2 0.0007
238 HAEMOGLOBIN INCREASED 3 0.0007
239 PRODUCT DISTRIBUTION ISSUE 6 0.0006
240 CONCUSSION 5 0.0006
241 INFUSION SITE EXTRAVASATION 4 0.0006
242 SKIN TIGHTNESS 3 0.0006
243 SWELLING OF EYELID 4 0.0006
244 SEASONAL ALLERGY 9 0.0006
245 SKIN INFECTION 7 0.0006
246 MIOSIS 5 0.0006
247 ANTINUCLEAR ANTIBODY POSITIVE 2 0.0006
248 POSTURE ABNORMAL 2 0.0006
249 LYMPHOCYTE COUNT INCREASED 2 0.0006
250 GASTROENTERITIS VIRAL 11 0.0006
251 NASAL POLYPS 3 0.0006
252 PANIC ATTACK 22 0.0006
253 DERMATITIS EXFOLIATIVE 3 0.0006
254 TONGUE ULCERATION 2 0.0006
255 CEREBELLAR INFARCTION 1 0.0006
256 BILIARY DYSKINESIA 1 0.0006
257 INITIAL INSOMNIA 6 0.0006
258 JOINT EFFUSION 4 0.0006
259 AMYLOIDOSIS 1 0.0006
260 BLOOD CHLORIDE INCREASED 1 0.0006
261 BURSITIS 7 0.0006
262 POLYMENORRHOEA 2 0.0006
263 HEART DISEASE CONGENITAL 2 0.0006
264 SKIN WEEPING 2 0.0006
265 GASTROINTESTINAL MOTILITY DISORDER 3 0.0006
266 GINGIVITIS 3 0.0006
267 STRESS FRACTURE 3 0.0006
268 BEHAVIOUR DISORDER 3 0.0006
269 RHABDOMYOLYSIS 23 0.0006
270 UTERINE LEIOMYOMA 4 0.0005
271 BODY TEMPERATURE ABNORMAL 1 0.0005
272 STREPTOCOCCAL INFECTION 3 0.0005
273 CANDIDA INFECTION 9 0.0005
274 AUTOIMMUNE THYROIDITIS 2 0.0005
275 PARANASAL SINUS DISCOMFORT 2 0.0005
276 THYROID MASS 2 0.0005
277 PANIC DISORDER 2 0.0005
278 ALCOHOL INTERACTION 1 0.0005
279 BLOOD PRESSURE SYSTOLIC INCREASED 10 0.0005
280 ADRENOCORTICAL INSUFFICIENCY ACUTE 1 0.0005
281 ABDOMINAL WALL HAEMATOMA 1 0.0005
282 TESTIS CANCER 2 0.0005
283 DRUG SCREEN POSITIVE 4 0.0005
284 POLYDIPSIA 2 0.0005
285 GINGIVAL PAIN 4 0.0005
286 HYPERPHAGIA 2 0.0005
287 RESPIRATORY TRACT INFECTION 13 0.0005
288 TRIGEMINAL NEURALGIA 2 0.0005
289 BODY TEMPERATURE INCREASED 10 0.0005
290 PANCREATITIS ACUTE 11 0.0005
291 INJECTION SITE MASS 18 0.0005
292 SELF-MEDICATION 2 0.0005
293 PHARYNGITIS 6 0.0005
294 AKINESIA 1 0.0005
295 MIDDLE INSOMNIA 9 0.0005
296 HALLUCINATIONS, MIXED 2 0.0005
297 ATTENTION DEFICIT HYPERACTIVITY DISORDER 2 0.0005
298 DRUG EFFECT LESS THAN EXPECTED 7 0.0005
299 UTERINE HAEMORRHAGE 2 0.0005
300 HEPATIC PAIN 2 0.0005
301 ILLNESS 48 0.0005
302 INCOHERENT 3 0.0005
303 PHARYNGITIS STREPTOCOCCAL 5 0.0005
304 CERVICAL DYSPLASIA 1 0.0005
305 SOMNAMBULISM 3 0.0005
306 CEREBELLAR SYNDROME 1 0.0005
307 ONYCHOMYCOSIS 2 0.0005
308 ORAL CANDIDIASIS 6 0.0005
309 GINGIVAL SWELLING 2 0.0005
310 INSOMNIA 119 0.0004
311 BRAIN FOG 7 0.0004
312 IRON DEFICIENCY 2 0.0004
313 FREQUENT BOWEL MOVEMENTS 12 0.0004
314 POSTOPERATIVE WOUND INFECTION 3 0.0004
315 EYE PAIN 25 0.0004
316 LUPUS-LIKE SYNDROME 4 0.0004
317 PALLOR 12 0.0004
318 HALLUCINATION, AUDITORY 7 0.0004
319 CONTRAINDICATED PRODUCT ADMINISTERED 13 0.0004
320 WITHDRAWAL SYNDROME 18 0.0004
321 COLITIS 16 0.0004
322 PRE-ECLAMPSIA 2 0.0004
323 SUICIDAL IDEATION 38 0.0004
324 TINNITUS 19 0.0004
325 EAR INFECTION 11 0.0004
326 AUTOIMMUNE DISORDER 4 0.0004
327 HORMONE LEVEL ABNORMAL 2 0.0004
328 COMPLETED SUICIDE 34 0.0004
329 CARDIOMEGALY 5 0.0004
330 CARTILAGE INJURY 1 0.0004
331 HYPERVOLAEMIA 2 0.0004
332 LIGAMENT SPRAIN 4 0.0004
333 SINUS DISORDER 8 0.0004
334 BLOOD IMMUNOGLOBULIN G DECREASED 1 0.0004
335 FLUID INTAKE REDUCED 2 0.0004
336 VEIN DISORDER 2 0.0004
337 DYSARTHRIA 15 0.0004
338 DYSPHORIA 2 0.0004
339 PATHOLOGICAL FRACTURE 2 0.0004
340 TOOTH ABSCESS 4 0.0004
341 HEPATIC CYTOLYSIS 5 0.0004
342 ANGLE CLOSURE GLAUCOMA 1 0.0004
343 ABDOMINAL INFECTION 1 0.0004
344 WEIGHT LOSS POOR 2 0.0004
345 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 10 0.0004
346 RESTLESS LEGS SYNDROME 7 0.0004
347 TENDERNESS 4 0.0004
348 WEIGHT FLUCTUATION 4 0.0004
349 AFFECTIVE DISORDER 3 0.0004
350 PULMONARY CONGESTION 5 0.0004
351 NASAL DISCOMFORT 3 0.0004
352 COMA 18 0.0004
353 PRODUCT PRESCRIBING ERROR 9 0.0004
354 RETCHING 8 0.0004
355 AREFLEXIA 1 0.0004
356 FOOD POISONING 2 0.0004
357 ABDOMINAL MASS 1 0.0004
358 ALCOHOL POISONING 1 0.0004
359 HEREDITARY ANGIOEDEMA 4 0.0004
360 BLOOD SODIUM INCREASED 1 0.0004
361 SINUS CONGESTION 5 0.0004
362 WEIGHT INCREASED 80 0.0004
363 EYE PRURITUS 12 0.0004
364 OCULAR DISCOMFORT 4 0.0004
365 EYE INFECTION 4 0.0004
366 INTENTIONAL PRODUCT USE ISSUE 31 0.0004
367 COVID-19 62 0.0004
368 HEART RATE INCREASED 35 0.0004
369 SINUSITIS 36 0.0004
370 GRANULOCYTOPENIA 2 0.0004
371 PREGNANCY 7 0.0003
372 INTENTIONAL SELF-INJURY 7 0.0003
373 UPPER RESPIRATORY TRACT INFECTION 16 0.0003
374 SKIN SWELLING 3 0.0003
375 STRESS CARDIOMYOPATHY 2 0.0003
376 BILIARY COLIC 1 0.0003
377 BLOOD CALCIUM INCREASED 3 0.0003
378 DECREASED INTEREST 2 0.0003
379 BRADYKINESIA 2 0.0003
380 PSYCHOTIC DISORDER 10 0.0003
381 COLITIS ULCERATIVE 15 0.0003
382 GASTROINTESTINAL INFECTION 3 0.0003
383 CENTRAL VENOUS CATHETERISATION 1 0.0003
384 FIBROMYALGIA 8 0.0003
385 ABNORMAL BEHAVIOUR 13 0.0003
386 MIGRAINE 31 0.0003
387 THYROID DISORDER 5 0.0003
388 INTERVERTEBRAL DISC DEGENERATION 3 0.0003
389 BRAIN DEATH 1 0.0003
390 ERYTHEMA MULTIFORME 3 0.0003
391 HYPERTENSION 68 0.0003
392 THERAPY PARTIAL RESPONDER 5 0.0003
393 PHOTOPHOBIA 6 0.0003
394 ABDOMINAL ADHESIONS 1 0.0003
395 BLADDER PAIN 1 0.0003
396 SLEEP APNOEA SYNDROME 6 0.0003
397 AGITATION 23 0.0003
398 INJURY 22 0.0003
399 GALACTORRHOEA 2 0.0003
400 HAEMOGLOBIN ABNORMAL 2 0.0003
401 SURGERY 18 0.0003
402 WALKING AID USER 2 0.0003
403 DEPRESSED LEVEL OF CONSCIOUSNESS 12 0.0003
404 TOXICITY TO VARIOUS AGENTS 51 0.0003
405 OVARIAN CYST 3 0.0003
406 URINARY RETENTION 10 0.0003
407 PRODUCT ADMINISTRATION ERROR 6 0.0003
408 WRONG PRODUCT ADMINISTERED 2 0.0003
409 FEEDING DISORDER 6 0.0003
410 GENERAL PHYSICAL CONDITION ABNORMAL 2 0.0003
411 ABNORMAL LOSS OF WEIGHT 2 0.0003
412 EUPHORIC MOOD 3 0.0003
413 RIB FRACTURE 6 0.0003
414 PERIPHERAL COLDNESS 4 0.0003
415 ONYCHOCLASIS 2 0.0003
416 POOR VENOUS ACCESS 3 0.0003
417 DROOLING 2 0.0003
418 MENTAL IMPAIRMENT 7 0.0003
419 DELIRIUM 10 0.0003
420 FORMICATION 2 0.0003
421 APHONIA 4 0.0003
422 DERMATITIS 6 0.0003
423 PRODUCT DOSE OMISSION ISSUE 84 0.0003
424 INCONTINENCE 3 0.0003
425 RENAL PAIN 3 0.0003
426 HEPATOCELLULAR INJURY 4 0.0003
427 SINUS TACHYCARDIA 4 0.0003
428 PANIC REACTION 2 0.0003
429 SKIN LACERATION 3 0.0003
430 MENTAL DISORDER 12 0.0003
431 COMPLICATION ASSOCIATED WITH DEVICE 4 0.0003
432 FAECES SOFT 2 0.0003
433 GASTROINTESTINAL PAIN 3 0.0003
434 INJECTION SITE NODULE 3 0.0003
435 ALCOHOL USE 1 0.0003
436 CEREBRAL DISORDER 2 0.0003
437 FUNGAL INFECTION 9 0.0003
438 SNEEZING 6 0.0003
439 THERAPEUTIC RESPONSE UNEXPECTED 12 0.0003
440 SEDATION 7 0.0003
441 HOT FLUSH 20 0.0003
442 DEVICE PHYSICAL PROPERTY ISSUE 2 0.0003
443 PROCEDURAL COMPLICATION 2 0.0003
444 EYE IRRITATION 15 0.0003
445 HAEMOLYSIS 2 0.0003
446 ATRIOVENTRICULAR BLOCK 2 0.0003
447 CONGENITAL ANOMALY 2 0.0003
448 EYELID OEDEMA 3 0.0003
449 LIMB INJURY 7 0.0003
450 DELUSION 4 0.0003
451 PELVIC FRACTURE 2 0.0003
452 INFUSION RELATED REACTION 17 0.0003
453 NASAL CONGESTION 15 0.0003
454 CYANOSIS 4 0.0003
455 FURUNCLE 2 0.0003
456 RENAL CYST 2 0.0003
457 AZOTAEMIA 1 0.0003
458 HYPONATRAEMIA 14 0.0002
459 FRUSTRATION TOLERANCE DECREASED 2 0.0002
460 SUICIDE ATTEMPT 15 0.0002
461 PRODUCT DOSE OMISSION IN ERROR 7 0.0002
462 POLYURIA 2 0.0002
463 PRODUCT PREPARATION ERROR 5 0.0002
464 ABASIA 6 0.0002
465 HAIR DISORDER 2 0.0002
466 INFLUENZA 27 0.0002
467 DRY EYE 12 0.0002
468 ACCIDENTAL EXPOSURE 1 0.0002
469 GAIT INABILITY 8 0.0002
470 HALLUCINATION, VISUAL 5 0.0002
471 INADEQUATE ANALGESIA 2 0.0002
472 JOINT INJURY 5 0.0002
473 MYDRIASIS 3 0.0002
474 PRODUCT CONTAINER ISSUE 2 0.0002
475 DRUG INTERACTION 37 0.0002
476 HYPERHIDROSIS 30 0.0002
477 SKIN CANCER 5 0.0002
478 APHASIA 7 0.0002
479 HIATUS HERNIA 3 0.0002
480 MUSCLE STRAIN 2 0.0002
481 PYELONEPHRITIS 2 0.0002
482 ATRIOVENTRICULAR BLOCK FIRST DEGREE 1 0.0002
483 PRODUCTIVE COUGH 11 0.0002
484 FATIGUE 179 0.0002
485 VERTIGO 14 0.0002
486 RESPIRATORY RATE INCREASED 2 0.0002
487 MALIGNANT MELANOMA 3 0.0002
488 HEAVY MENSTRUAL BLEEDING 2 0.0002
489 CHILLS 26 0.0002
490 HYPOAESTHESIA 33 0.0002
491 DRUG TOXICITY 3 0.0002
492 BLOOD THYROID STIMULATING HORMONE DECREASED 1 0.0002
493 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
494 BONE DISORDER 4 0.0002
495 OSTEOPOROSIS 9 0.0002
496 RESPIRATORY ARREST 6 0.0002
497 NERVE COMPRESSION 2 0.0002
498 BLOOD PRESSURE DIASTOLIC INCREASED 1 0.0002
499 IRON DEFICIENCY ANAEMIA 2 0.0002
500 GRAND MAL CONVULSION 2 0.0002
501 MENTAL STATUS CHANGES 6 0.0002
502 HUNGER 3 0.0002
503 EYE SWELLING 8 0.0002
504 BACTERIAL INFECTION 4 0.0002
505 CARPAL TUNNEL SYNDROME 3 0.0002
506 TACHYCARDIA 19 0.0002
507 SLEEP DISORDER 15 0.0002
508 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 38 0.0002
509 CARDIAC TAMPONADE 1 0.0002
510 ECZEMA 11 0.0002
511 DERMATITIS ATOPIC 11 0.0002
512 WHITE BLOOD CELL COUNT INCREASED 8 0.0002
513 BALANCE DISORDER 18 0.0002
514 APHAGIA 1 0.0002
515 HYPERCHOLESTEROLAEMIA 2 0.0002
516 LOCALISED INFECTION 5 0.0002
517 DIZZINESS POSTURAL 2 0.0002
518 NEURALGIA 5 0.0002
519 HAEMORRHOIDS 4 0.0002
520 PHARYNGEAL SWELLING 2 0.0002
521 SKIN HAEMORRHAGE 3 0.0002
522 PRODUCT USE IN UNAPPROVED INDICATION 50 0.0002
523 ABDOMINAL TENDERNESS 1 0.0002
524 ANEURYSM 1 0.0002
525 PNEUMONIA ASPIRATION 5 0.0002
526 AGGRESSION 10 0.0002
527 BRAIN INJURY 2 0.0002
528 HYPOAESTHESIA ORAL 3 0.0002
529 ANXIETY 56 0.0002
530 FLUSHING 20 0.0002
531 SUBARACHNOID HAEMORRHAGE 2 0.0002
532 BLOOD PRESSURE INCREASED 30 0.0002
533 FEELING ABNORMAL 47 0.0002
534 AMMONIA INCREASED 1 0.0002
535 PHARYNGEAL OEDEMA 3 0.0002
536 DEVICE RELATED INFECTION 3 0.0002
537 EAR DISCOMFORT 2 0.0002
538 MOBILITY DECREASED 14 0.0002
539 INJECTION SITE WARMTH 4 0.0002
540 INFLUENZA LIKE ILLNESS 16 0.0002
541 TEMPERATURE INTOLERANCE 2 0.0002
542 ANKLE FRACTURE 3 0.0002
543 TENDONITIS 3 0.0002
544 UNRESPONSIVE TO STIMULI 5 0.0002
545 SKELETAL INJURY 2 0.0002
546 VENTRICULAR EXTRASYSTOLES 2 0.0002
547 EYE DISCHARGE 2 0.0002
548 CONVULSION 11 0.0002
549 UNDERDOSE 14 0.0002
550 ACCIDENTAL OVERDOSE 7 0.0002
551 FOLLICULITIS 2 0.0002
552 INJECTION SITE DISCOMFORT 2 0.0002
553 GASTRITIS 5 0.0002
554 MULTIPLE SCLEROSIS RELAPSE 13 0.0002
555 OCULAR HYPERAEMIA 9 0.0002
556 PANCREATITIS 10 0.0002
557 BRONCHITIS 14 0.0002
558 CYSTITIS 6 0.0002
559 ANORECTAL DISCOMFORT 1 0.0002
560 ABSCESS 3 0.0002
561 MOVEMENT DISORDER 6 0.0002
562 ANAL ABSCESS 1 0.0002
563 DECREASED ACTIVITY 2 0.0002
564 MUSCLE TIGHTNESS 3 0.0002
565 MENSTRUATION DELAYED 2 0.0002
566 NASOPHARYNGITIS 34 0.0002
567 BIPOLAR DISORDER 2 0.0002
568 PULMONARY THROMBOSIS 2 0.0002
569 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
570 HYPERSENSITIVITY 34 0.0002
571 CHOLELITHIASIS 6 0.0002
572 ASPIRATION 2 0.0002
573 MANIA 3 0.0002
574 ASTHENOPIA 1 0.0002
575 STAPHYLOCOCCAL INFECTION 6 0.0002
576 AUTISM SPECTRUM DISORDER 1 0.0002
577 DRUG LEVEL INCREASED 3 0.0002
578 ABNORMAL DREAMS 5 0.0002
579 ASTHENIA 68 0.0002
580 PSYCHOMOTOR HYPERACTIVITY 3 0.0002
581 RED BLOOD CELL SEDIMENTATION RATE INCREASED 2 0.0002
582 TOOTH DISORDER 4 0.0002
583 NERVE INJURY 2 0.0002
584 TYPE 2 DIABETES MELLITUS 6 0.0002
585 HEMIPARESIS 3 0.0002
586 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 3 0.0002
587 INTENTIONAL DOSE OMISSION 5 0.0002
588 MICTURITION URGENCY 2 0.0002
589 HYPERSOMNIA 5 0.0002
590 SOMNOLENCE 35 0.0002
591 MUSCLE TWITCHING 4 0.0002
592 DRY MOUTH 14 0.0002
593 BACK PAIN 40 0.0002
594 ELECTROLYTE IMBALANCE 2 0.0002
595 DEPRESSION 39 0.0002
596 SEXUAL DYSFUNCTION 2 0.0002
597 COLD SWEAT 3 0.0002
598 TREMOR 28 0.0002
599 NEUROLEPTIC MALIGNANT SYNDROME 2 0.0002
600 CATARACT OPERATION 1 0.0002
601 DRUG ABUSE 14 0.0002
602 URTICARIA 28 0.0002
603 DISTURBANCE IN ATTENTION 9 0.0002
604 WRIST FRACTURE 2 0.0002
605 ELECTROCARDIOGRAM QT PROLONGED 6 0.0002
606 OEDEMA 9 0.0002
607 INFECTION 24 0.0002
608 HEPATITIS C 2 0.0002
609 LACRIMATION INCREASED 5 0.0002
610 PARAESTHESIA 26 0.0002
611 FALL 55 0.0002
612 ADRENAL INSUFFICIENCY 2 0.0002
613 SCHIZOPHRENIA 2 0.0002
614 TREATMENT NONCOMPLIANCE 9 0.0002
615 RESTLESSNESS 6 0.0002
616 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
617 HEADACHE 102 0.0002
618 SMALL INTESTINAL OBSTRUCTION 2 0.0002
619 SPINAL OPERATION 2 0.0002
620 MALAISE 71 0.0002
621 GENERALISED OEDEMA 2 0.0002
622 FEMUR FRACTURE 5 0.0002
623 NECK PAIN 9 0.0002
624 TOOTH EXTRACTION 2 0.0002
625 SWOLLEN TONGUE 5 0.0002
626 HALLUCINATION 12 0.0002
627 BLEPHAROSPASM 1 0.0002
628 BRAIN OEDEMA 2 0.0002
629 FOOT FRACTURE 3 0.0002
630 INCREASED APPETITE 3 0.0002
631 BURNING SENSATION 11 0.0002
632 PULMONARY OEDEMA 7 0.0002
633 GASTROINTESTINAL DISORDER 14 0.0002
634 CHOLESTASIS 3 0.0002
635 POST PROCEDURAL COMPLICATION 3 0.0002
636 ERECTILE DYSFUNCTION 4 0.0002
637 ROTATOR CUFF SYNDROME 2 0.0002
638 ANOREXIA 2 0.0002
639 NIGHT SWEATS 5 0.0002
640 PRESCRIBED OVERDOSE 3 0.0002
641 CARDIAC FLUTTER 1 0.0002
642 INJECTION SITE INDURATION 2 0.0002
643 KIDNEY INFECTION 3 0.0002
644 TOOTH INFECTION 2 0.0002
645 SARS-COV-2 TEST POSITIVE 2 0.0002
646 CONDITION AGGRAVATED 46 0.0002
647 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
648 APPETITE DISORDER 1 0.0002
649 THERAPEUTIC RESPONSE SHORTENED 5 0.0002
650 LIP SWELLING 5 0.0001
651 COGNITIVE DISORDER 7 0.0001
652 QUALITY OF LIFE DECREASED 2 0.0001
653 BREAST MASS 1 0.0001
654 LOSS OF CONSCIOUSNESS 19 0.0001
655 DRUG WITHDRAWAL SYNDROME 13 0.0001
656 DYSKINESIA 6 0.0001
657 NEUROPATHY PERIPHERAL 14 0.0001
658 PNEUMONITIS 4 0.0001
659 HEPATIC ENZYME INCREASED 10 0.0001
660 MULTIPLE SCLEROSIS 7 0.0001
661 INJECTION SITE REACTION 10 0.0001
662 PALPITATIONS 17 0.0001
663 POLLAKIURIA 6 0.0001
664 AUTOIMMUNE HEPATITIS 1 0.0001
665 ROAD TRAFFIC ACCIDENT 6 0.0001
666 COORDINATION ABNORMAL 2 0.0001
667 MASS 2 0.0001
668 WOUND 4 0.0001
669 DEVICE OCCLUSION 2 0.0001
670 TARDIVE DYSKINESIA 4 0.0001
671 PAIN IN JAW 4 0.0001
672 EATING DISORDER 3 0.0001
673 INTENTIONAL OVERDOSE 9 0.0001
674 PAIN 86 0.0001
675 SYNCOPE 14 0.0001
676 PARALYSIS 2 0.0001
677 LETHARGY 8 0.0001
678 SEIZURE 16 0.0001
679 PULMONARY ARTERIAL HYPERTENSION 2 0.0001
680 INJECTION SITE HAEMATOMA 2 0.0001
681 HYPOKINESIA 2 0.0001
682 PRODUCT DISPENSING ERROR 3 0.0001
683 NAUSEA 109 0.0001
684 FLUID RETENTION 7 0.0001
685 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
686 MUSCULOSKELETAL STIFFNESS 12 0.0001
687 THERAPY CESSATION 7 0.0001
688 MUSCLE SPASMS 25 0.0001
689 WEIGHT DECREASED 38 0.0001
690 ABDOMINAL PAIN UPPER 28 0.0001
691 INFLAMMATION 7 0.0001
692 BLOOD PRESSURE DECREASED 9 0.0001
693 HYPOTENSION 27 0.0001
694 PULMONARY MASS 2 0.0001
695 GLOSSODYNIA 3 0.0001
696 NERVOUSNESS 7 0.0001
697 CARDIAC ARREST 11 0.0001
698 IRRITABILITY 8 0.0001
699 BREAST TENDERNESS 1 0.0001
700 HEART RATE IRREGULAR 3 0.0001
701 DIZZINESS 66 0.0001
702 MUSCULAR WEAKNESS 15 0.0001
703 ECONOMIC PROBLEM 2 0.0001
704 OSTEOPENIA 2 0.0001
705 EPILEPSY 4 0.0001
706 ACIDOSIS 1 0.0001
707 HIP ARTHROPLASTY 2 0.0001
708 PERICARDIAL EFFUSION 3 0.0001
709 APHTHOUS ULCER 1 0.0001
710 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 1 0.0001
711 NERVOUS SYSTEM DISORDER 4 0.0001
712 MENINGIOMA 2 0.0001
713 PRODUCT USE COMPLAINT 2 0.0001
714 CHEST DISCOMFORT 13 0.0001
715 DISORIENTATION 5 0.0001
716 PNEUMOTHORAX 2 0.0001
717 BLOOD ALBUMIN DECREASED 1 0.0001
718 RESPIRATORY TRACT CONGESTION 2 0.0001
719 OBESITY 2 0.0001
720 GAIT DISTURBANCE 24 0.0001
721 HYPOTHYROIDISM 4 0.0001
722 ABDOMINAL DISCOMFORT 21 0.0001
723 DIABETIC KETOACIDOSIS 3 0.0001
724 BLOOD DISORDER 1 0.0001
725 SENSORY DISTURBANCE 2 0.0001
726 THROMBOSIS 10 0.0001
727 RHINORRHOEA 8 0.0001
728 PRESYNCOPE 3 0.0001
729 URINARY TRACT INFECTION 21 0.0001
730 LUNG DISORDER 6 0.0001
731 PRURITUS 47 0.0001
732 ABNORMAL FAECES 1 0.0001
733 VOMITING 57 0.0001
734 BLOOD ALKALINE PHOSPHATASE INCREASED 3 0.0001
735 INJECTION SITE PAIN 37 0.0001
736 EXPIRED PRODUCT ADMINISTERED 4 0.0001
737 INJECTION SITE PRURITUS 8 0.0001
738 CONSTIPATION 26 0.0001
739 DRUG INEFFECTIVE 156 0.0001
740 ANGER 4 0.0001
741 PRODUCT USE ISSUE 22 0.0001
742 HAEMATURIA 4 0.0001
743 VISION BLURRED 16 0.0001
744 MUSCULOSKELETAL DISCOMFORT 2 0.0001
745 ANURIA 1 0.0001
746 PARANOIA 2 0.0001
747 BLOOD MAGNESIUM DECREASED 1 0.0001
748 EXPOSURE VIA SKIN CONTACT 3 0.0001
749 NIGHTMARE 4 0.0001
750 CARDIAC MURMUR 1 0.0001
751 DEVICE DEFECTIVE 2 0.0001
752 ILL-DEFINED DISORDER 7 0.0001
753 ASTHMA 13 0.0001
754 ABDOMINAL DISTENSION 12 0.0001
755 DEAFNESS 3 0.0001
756 SPEECH DISORDER 6 0.0001
757 JOINT STIFFNESS 3 0.0001
758 DEPRESSED MOOD 6 0.0001
759 CHEST PAIN 21 0.0001
760 LYMPHOCYTE COUNT DECREASED 2 0.0001
761 ARTHRALGIA 47 0.0001
762 DRUG ERUPTION 2 0.0001
763 SYSTEMIC LUPUS ERYTHEMATOSUS 4 0.0001
764 BREAST CANCER FEMALE 3 0.0001
765 THIRST 2 0.0001
766 DYSPEPSIA 11 0.0001
767 MYALGIA 19 0.0001
768 GOUT 2 0.0001
769 THROAT TIGHTNESS 3 0.0001
770 LEUKOCYTOSIS 2 0.0001
771 PELVIC PAIN 2 0.0001
772 CRYING 4 0.0001
773 C-REACTIVE PROTEIN INCREASED 4 0.0001
774 HYPERGLYCAEMIA 4 0.0001
775 RESPIRATORY FAILURE 8 0.0001
776 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 6 0.0001
777 MEMORY IMPAIRMENT 15 0.0001
778 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
779 OROPHARYNGEAL PAIN 10 0.0001
780 FEELING COLD 3 0.0001
781 AMNESIA 7 0.0001
782 BLOOD CHOLESTEROL INCREASED 5 0.0001
783 PYREXIA 37 0.0001
784 ABORTION INDUCED 1 0.0001
785 HYPOCALCAEMIA 2 0.0001
786 RENAL FAILURE 14 0.0001
787 DISEASE RECURRENCE 5 0.0001
788 MUSCULOSKELETAL DISORDER 2 0.0001
789 FEELING JITTERY 2 0.0001
790 RASH ERYTHEMATOUS 5 0.0001
791 DYSPNOEA 59 0.0001
792 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 5 0.0001
793 AFFECT LABILITY 1 0.0001
794 HERNIA 2 0.0001
795 COUGH 29 0.0001
796 DYSTONIA 2 0.0001
797 EAR PAIN 2 0.0001
798 DYSSTASIA 3 0.0001
799 CHOKING 2 0.0001
800 DIARRHOEA 66 0.0001
801 BODY TEMPERATURE DECREASED 1 0.0001
802 DISABILITY 2 0.0001
803 BLOOD PRESSURE ABNORMAL 2 0.0001
804 UPPER LIMB FRACTURE 2 0.0001
805 PRESCRIBED UNDERDOSE 2 0.0001
806 ABORTION SPONTANEOUS 4 0.0001
807 EMOTIONAL DISTRESS 12 0.0001
808 RASH 43 0.0001
809 FEELING HOT 6 0.0001
810 DRY SKIN 13 0.0001
811 PERIPHERAL SWELLING 15 0.0001
812 LIMB DISCOMFORT 3 0.0001
813 TOOTH LOSS 2 0.0001
814 KNEE ARTHROPLASTY 2 0.0001
815 MOUTH ULCERATION 2 0.0001
816 DECREASED APPETITE 22 0.0001
817 PULMONARY EMBOLISM 9 0.0001
818 ABDOMINAL PAIN 22 0.0001
819 OSTEOARTHRITIS 4 0.0001
820 RENAL FAILURE ACUTE 4 0.0001
821 BODY HEIGHT DECREASED 1 0.0001
822 IRRITABLE BOWEL SYNDROME 2 0.0001
823 DRUG INTOLERANCE 9 0.0001
824 CONFUSIONAL STATE 15 0.0001
825 UNEVALUABLE EVENT 7 0.0001
826 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
827 RASH PRURITIC 5 0.0001
828 SWELLING FACE 6 0.0001
829 DIABETES MELLITUS 7 0.0001
830 PAIN IN EXTREMITY 27 0.0001
831 IMPAIRED HEALING 3 0.0001
832 BLOOD GLUCOSE FLUCTUATION 1 0.0001
833 ANAPHYLACTIC REACTION 5 0.0001
834 ANGIOEDEMA 4 0.0001
835 RASH MACULO-PAPULAR 2 0.0001
836 HEPATOTOXICITY 2 0.0001
837 PNEUMONIA 29 0.0001
838 THERAPEUTIC PRODUCT EFFECT DECREASED 4 0.0001
839 RASH PAPULAR 2 0.0001
840 THROAT IRRITATION 4 0.0001
841 OXYGEN SATURATION DECREASED 5 0.0001
842 BLOOD CALCIUM DECREASED 1 0.0001
843 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
844 OVERDOSE 19 0.0001
845 LOWER RESPIRATORY TRACT INFECTION 4 0.0001
846 RASH MACULAR 3 0.0001
847 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 4 0.0001
848 TREATMENT FAILURE 7 0.0001
849 BLOOD IRON DECREASED 1 0.0001
850 BACTERAEMIA 1 0.0001
851 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 17 0.0001
852 BLOOD PRESSURE FLUCTUATION 2 0.0001
853 DEHYDRATION 11 0.0001
854 DISCOMFORT 5 0.0001
855 INJECTION SITE URTICARIA 2 0.0001
856 LIVER INJURY 2 0.0001
857 ABNORMAL WEIGHT GAIN 1 0.0001
858 OSTEONECROSIS OF JAW 2 0.0001
859 INJECTION SITE ERYTHEMA 10 0.0001
860 EPISTAXIS 6 0.0001
861 DYSPNOEA EXERTIONAL 3 0.0001
862 OFF LABEL USE 69 0.0001
863 ADVERSE DRUG REACTION 7 0.0001
864 ACCIDENTAL EXPOSURE TO PRODUCT 8 0.0001
865 HAEMATOMA 2 0.0001
866 ARTHRITIS 6 0.0001
867 ANKYLOSING SPONDYLITIS 1 0.0001
868 BRADYCARDIA 4 0.0001
869 GASTROOESOPHAGEAL REFLUX DISEASE 6 0.0001
870 FEAR 2 0.0001
871 JAUNDICE 2 0.0001
872 BLOOD BILIRUBIN INCREASED 2 0.0001
873 SKIN LESION 2 0.0001
874 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
875 RESPIRATORY DISTRESS 2 0.0001
876 DIVERTICULITIS 2 0.0001
877 ARTHROPATHY 4 0.0001
878 ATRIAL FIBRILLATION 7 0.0001
879 PANCYTOPENIA 4 0.0001
880 BLISTER 4 0.0001
881 SKIN EXFOLIATION 6 0.0001
882 RHEUMATOID ARTHRITIS 8 0.0001
883 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
884 BRONCHOSPASM 1 0.0001
885 HYPOACUSIS 3 0.0001
886 ACCIDENTAL UNDERDOSE 1 0.0001
887 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
888 NEEDLE ISSUE 2 0.0001
889 APATHY 1 0.0001
890 PRODUCT STORAGE ERROR 6 0.0001
891 BONE PAIN 4 0.0001
892 ANAEMIA 13 0.0001
893 CARDIOMYOPATHY 1 0.0001
894 DEVICE ISSUE 6 0.0001
895 RESPIRATORY DISORDER 2 0.0001
896 THERAPY NON-RESPONDER 3 0.0001
897 ALOPECIA 13 0.0001
898 SKIN IRRITATION 3 0.0001
899 INJECTION SITE SWELLING 5 0.0001
900 HYPOKALAEMIA 3 0.0001
901 GYNAECOMASTIA 2 0.0001
902 BASAL CELL CARCINOMA 1 0.0001
903 ARRHYTHMIA 3 0.0001
904 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
905 HIP FRACTURE 2 0.0001
906 BACK DISORDER 1 0.0001
907 INCORRECT DOSE ADMINISTERED 14 0.0001
908 EYE DISORDER 2 0.0001
909 FEBRILE NEUTROPENIA 4 0.0001
910 LEUKOPENIA 3 0.0001
911 GASTROINTESTINAL HAEMORRHAGE 5 0.0001
912 BLOOD UREA INCREASED 1 0.0001
913 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
914 DRUG EXPOSURE DURING PREGNANCY 2 0.0001
915 HAEMORRHAGE 6 0.0001
916 INTENTIONAL PRODUCT MISUSE 5 0.0001
917 HYPOXIA 2 0.0001
918 DRUG DEPENDENCE 9 0.0001
919 THERAPY INTERRUPTED 4 0.0001
920 CEREBRAL HAEMORRHAGE 2 0.0001
921 SKIN BURNING SENSATION 4 0.0001
922 DRUG EFFECT DECREASED 3 0.0001
923 DYSURIA 2 0.0001
924 AGRANULOCYTOSIS 1 0.0001
925 THROMBOCYTOPENIA 6 0.0001
926 ERYTHEMA 11 0.0001
927 SWELLING 5 0.0001
928 BLOOD GLUCOSE INCREASED 10 0.0001
929 FLATULENCE 3 0.0001
930 BLOOD URINE PRESENT 1 0.0001
931 NEUTROPENIA 7 0.0001
932 WHEEZING 3 0.0001
933 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
934 STOMATITIS 3 0.0000
935 PSORIATIC ARTHROPATHY 2 0.0000
936 OEDEMA PERIPHERAL 6 0.0000
937 BONE MARROW FAILURE 1 0.0000
938 LUNG NEOPLASM MALIGNANT 2 0.0000
939 VISUAL IMPAIRMENT 6 0.0000
940 CARDIO-RESPIRATORY ARREST 2 0.0000
941 RECTAL HAEMORRHAGE 2 0.0000
942 DEEP VEIN THROMBOSIS 3 0.0000
943 VAGINAL HAEMORRHAGE 2 0.0000
944 BLOOD CREATININE INCREASED 3 0.0000
945 ACUTE KIDNEY INJURY 7 0.0000
946 HOSPITALISATION 7 0.0000
947 LIVER DISORDER 2 0.0000
948 NEOPLASM MALIGNANT 3 0.0000
949 PRODUCT QUALITY ISSUE 6 0.0000
950 NEPHROLITHIASIS 2 0.0000
951 DYSPHAGIA 4 0.0000
952 JOINT SWELLING 5 0.0000
953 HYPOGLYCAEMIA 2 0.0000
954 CEREBRAL INFARCTION 1 0.0000
955 ACNE 3 0.0000
956 HAEMOGLOBIN DECREASED 4 0.0000
957 ANAPHYLACTIC SHOCK 1 0.0000
958 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
959 INJECTION SITE BRUISING 3 0.0000
960 PROSTATE CANCER 3 0.0000
961 FOETAL EXPOSURE DURING PREGNANCY 3 0.0000
962 WHITE BLOOD CELL COUNT DECREASED 4 0.0000
963 DEPENDENCE 2 0.0000
964 ANGINA PECTORIS 1 0.0000
965 GENERAL PHYSICAL HEALTH DETERIORATION 4 0.0000
966 DYSPHONIA 2 0.0000
967 ASCITES 1 0.0000
968 ACUTE MYOCARDIAL INFARCTION 1 0.0000
969 BLOOD POTASSIUM DECREASED 1 0.0000
970 PLEURAL EFFUSION 2 0.0000
971 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
972 BREAST CANCER 3 0.0000
973 EXPOSURE DURING PREGNANCY 2 0.0000
974 CARDIAC DISORDER 3 0.0000
975 DEVICE MALFUNCTION 2 0.0000
976 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
977 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
978 DEATH 24 0.0000
979 NO ADVERSE EVENT 5 0.0000
980 DYSGEUSIA 2 0.0000
981 SEPSIS 3 0.0000
982 DISEASE PROGRESSION 3 0.0000
983 CARDIAC FAILURE 2 0.0000
984 BLINDNESS 1 0.0000
985 DRUG DOSE OMISSION 4 0.0000
986 PSORIASIS 3 0.0000
987 ADVERSE EVENT 2 0.0000
988 BLOOD GLUCOSE DECREASED 1 0.0000
989 PLATELET COUNT DECREASED 2 0.0000
990 CEREBROVASCULAR ACCIDENT 3 0.0000
991 MYOCARDIAL INFARCTION 3 0.0000
992 BLADDER CANCER 1 0.0000
993 CARDIAC FAILURE CONGESTIVE 1 0.0000